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 
Abstract—The aim of this study was to investigate the effect of 
opioids on electroencephalogram (EEG) indices of nociception in 
cats undergoing castration. Cats were randomly assigned to 
receive one of the four treatments (n=8); 0.2 mg/kg morphine, 
0.005 mg/ kg fentanyl, 0.01 mg/kg buprenorphine or 0.2 mg/kg 
butorphanol, administered subcutaneously (SC) at the time of pre-
anesthetic medication. Anesthesia was induced with intravenous 
propofol and maintained with halothane in oxygen. EEG was 
recorded continuously in a three electrode montage. Median 
frequency (F50), total power (PTOT) and 95% spectral edge 
frequency (F95) derived from the EEG power spectra recorded 
prior to skin incision (baseline) were compared with those 
recorded during the ligation of the spermatic cords of both 
testicles. During the ligation of testicle 1, the mean F50 of cats that 
received buprenorphine and butorphanol was significantly 
(p<0.05) higher, compared with baseline values. During the 
ligation of testicle 2, the cats in the butorphanol and fentanyl 
groups showed significantly (p<0.05) higher F50 values, compared 
with that of the morphine group as well as with their respective 
values during the ligation of testicle 1. Ptot values decreased 
significantly (p<0.05) in all the treatment groups (excluding 
morphine after the removal of testicle 2), compared with baseline 
values. Morphine treated cats had significantly (p<0.05) higher Ptot 
values than cats in the buprenorphine and fentanyl groups during 
the removal of both testicles. The F95 of the EEG did not differ 
between the two groups during the ligation of either testicle 
(p>0.05). These results indicate that opioid analgesics, acting at 
different opioid receptors with variable affinity, produce changes 
in the EEG responses that reflect their anti-nociceptive efficacy. 
This study demonstrates the usefulness of the EEG as a valid tool 
for evaluating analgesic efficacy in cats, as shown in other species 
of animals in previous studies. 
 
Index Terms – Electroencephalogram, castration, analgesia, cat, 
opiods, morphine,  fentanyl, butorphanol, buprenorphine  
 
I.  INTRODUCTION 
 
ROVISION of adequate analgesia following surgical 
procedures or trauma is a vital element of animal welfare. 
Currently, very limited approved medication is available for the 
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other species, especially dogs. This is likely, in large part, due 
to the lack of validated techniques to reliably identify and assess 
cat pain [1]. Owing to their unique temperament and minimal 
expression of pain behaviors, assessing and treating pain based 
on behavioral observation is less effective [1]. This often leads 
to underestimation of the level of pain that a cat experiences. 
 
Development of objective and repeatable methods for 
assessment and management of pain in cats is essential [2].  
Electroencephalography (EEG) has been used to objectively 
assess pain and analgesia in other animals [3]. Changes in EEG 
activity correlate with verbal reports of pain experience in 
people, and with behavioral responses to nociceptive stimuli in 
conscious sheep [4, 5]. The commonly used quantitative 
variables of the EEG power spectrum in response to nociception 
are median frequency (F50), 95% spectral edge frequency (SEF 
or F95) and total EEG power (Ptot) [6, 7]. The F50 and F95 are the 
frequencies below which 50% and 95%, respectively, of the 
total power of the EEG is located, and the PTOT is the total area 
under the EEG power spectrum curve. For further details of 
these variables see the review by Murrell and Johnson [3].  
 
Opioids are effective in controlling perioperative pain in 
veterinary patients. Quantitative analysis of EEG power spectra 
has been used to evaluate the efficacy of opioids and α2- agonist 
analgesics in anaesthetized dogs, and to correlate EEG changes 
with the pharmacokinetic properties of these agents [8-10]. 
However, no studies have been undertaken on the use of EEG 
in measuring the analgesic efficacy of opioids (or any other 
analgesics) in response to noxious stimulation in the cat. 
 
Ovariohysterectomy and castration are the most common 
surgical procedures in small animal practice. These can cause 
significant postoperative pain [11]. Since these elective 
surgeries are performed routinely on healthy and pain-free 
animals, the efficacy of analgesic drugs or assessment 
techniques can be reliably evaluated, assuming that the 
resulting pain is solely due to surgery [12].   
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The aim of the present study was to investigate the effects 
of four opioids on EEG indices of nociception in cats 
undergoing castration surgery. Also, the validity of the EEG to 
evaluate the anti-nociceptive efficacy of opioids in cats was 
tested. The hypothesis tested was that opioids administered 
prior to castration would change the EEG indices of 
nociception, and that EEG can be used as a reliable method to 
assess analgesia in cats. 
 
II. MATERIALS AND METHODS 
 
A. Experimental Design 
The study was approved by the Massey University Animal 
Ethics Committee. Thirty two mixed breed cats admitted for 
castration were recruited for the trial. The mean body weight of 
the cats was 3.5 kg (range, 1.6 to 4.2 kg). The age of the cats 
ranged from 5 to 12 months. Only clinically normal cats, as 
assessed by routine physical examination and clinical 
biochemistry and hematology, were included in the study. Cats 
were randomly assigned to receive one of the four treatments 
(n=8 per treatment group): 0.2 mg/kg morphine (Morphine 
Sulfate Injection, Mayne Pharma Pty Ltd, Mulgrave, Victoria, 
Australia), 0.005 mg/kg fentanyl (Fentanyl citrate injection, 
Abbott laboratories, Chicago, IL, USA), 0.01 mg/kg 
buprenorphine (Temgesic® injection, Reckitt Benckiser 
pharmaceutical Inc., West Ryde, NSW, Australia) or 0.2 mg/kg 
butorphanol (Torbugesic® Butorphanol Tartrate, Fort dodge 
Australia Pty Limited, NSW, Australia ). These drugs were 
administered subcutaneously (SC), at the same time as pre- 
anesthetic medication.  
B. Anesthesia  
All animals received 0.05 mg/kg acepromazine SC 
(Acezine 2, Delta Veterinary Laboratories, NewSouth Wales, 
Australia) as pre-anesthetic medication. Respective test drugs 
were also administered at this time. Forty five minutes after pre-
anesthetic administration, anesthesia was induced with 
intravenous (IV) propofol (Propofol Injection, Mayne Pharma 
Pty Ltd, Mulgrave, Victoria, Australia) to effect and maintained 
with halothane in oxygen. The concentration of halothane was 
adjusted to keep the cat at a suitable plane of surgical 
anesthesia, as judged by the anesthetist. As soon as the cat was 
anaesthetized and its airway, breathing and circulation had been 
checked, a pulse oximeter (Pulse Ox, Fisher & Paykel 
Healthcare Ltd, Auckland, NZ) and Doppler transducer 
(Doppler flow detector, Parks medical electronics Inc, Oregon, 
USA) with an appropriate cuff for each cat, were attached to 
monitor arterial hemoglobin oxygen saturation and blood 
pressure non-invasively. Airway gases were sampled 
continuously from the end of endotracheal tube connected to 
the T-piece, using an anesthetic gas analyzer (Hewlet Packard 
M1025B, Hewlet Packard, Hamburg, Germany). All animals 
breathed spontaneously throughout anesthesia and end-tidal 
CO2 tension was maintained between 4.60 and 5.92 kPa (35 and 
45 mmHg), using intermittent positive pressure ventilation. 
Body temperature was monitored in all animals using an 
esophageal thermistor probe and was maintained between 37 
and 38°C with a circulating warm water blanket heating device. 
Respiratory rate, heart rate, end-tidal halothane tension (ETHal) 
and end-tidal CO2 tension (ETCO2) of each cat were also 
monitored using an anesthetic agent monitor (Hewlett Packard 
M1025B, Hewlett Packard, Hamburg, Germany). 
C. EEG and Electrocardiogram (ECG) Recording  
EEG was recorded using an Apple Macintosh personal 
computer installed with Chart 5.2.2 recording software and 
connected to Powerlab 4/20 data recording system (PowerlabTM 
data acquisition system, AD Instruments Ltd, Sydney, 
Australia). Three 27 SWG stainless steel needle electrodes 
(Medelec, Radiometer, Auckland, New Zealand) were placed 
subcutaneously, with the inverting electrode over the zygomatic 
process of the left frontal bone, the non-inverting electrode over 
the left mastoid process and the ground electrode caudal to the 
occipital process [3]. The EEG recording was started as soon as 
the cat was stabilized under anesthesia, with a sample rate of 1 
kHz and a pass band of 0.5–400 Hz using an amplifier and 
analogue to digital converter (Alert System, Medlec, Surrey, 
UK). All animals were castrated using a routine scrotal 
approach.  EEG data from 180-second blocks immediately 
preceding the skin incision were sampled as the baseline time 
period (at least 40 min after induction of anesthesia). Data from 
180-second blocks following clamping of the spermatic cord of 
each testicle were measured as testicle 1 (T1) and testicle 2 (T2). 
Data were averaged over the 180-second blocks at each data 
point for statistical comparisons. 
 
EEG epochs contaminated by movement artifacts were 
manually rejected from analysis of raw EEG data. Data were 
multiplied using a Welch window and fast Fourier 
transformation applied to each epoch, generating sequential 
power spectra with 1 Hz frequency bins.  F50, F95 and Ptot of the 
EEG power spectra were calculated using a Spectral Analyser 
(CB Johnson, Massey University, Palmerston North, NZ, 2002) 
and used for statistical comparisons. 
D. Statistical Analyses  
EEG variables (F50, F95 and PTOT), recorded during a three 
minute baseline period (before surgery began) and three 
minutes during the removal of each testicle (T1 and T2), were 
compared between treatment groups as well as between the two 
surgical periods within a group, using generalized linear mixed 
model analysis [13] in SAS® 9.3 (SAS Institute Inc. Cary, NC, 
USA). The linear mixed model included the fixed effects of 
treatments, time and their interaction, and random effects of 
animals. Baseline values were treated as a covariate. The 
covariance error structure for repeated measures over the two 
surgical periods (T1 and T2), within animals within group was 
determined using Akaike’s information criterion. A first-order 
autoregressive model was found to be the most appropriate 
error structure. EEG variables were tested for normality using 
Shapiro-Wilk, Kolmogorov-Smirnov, Anderson-Darling, and 
Cramér-von Mises tests in SAS® 9.3. Since the residuals of data 
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were not normally distributed, log-transformed variables were 
used in the analyses and the resulting least square means in 
logarithmic scale were used for graphical presentations. Heart 
rate, respiratory rate, ETHal and ETCO2 of the cats recorded at 5-
minute intervals during surgery were also analyzed as repeated 




During the removal of T1, the mean F50 of cats in the 
buprenorphine and butorphanol groups increased significantly 
(p<0.05), compared with their respective baseline values (Fig. 
1). Although the F50 of cats in the morphine and fentanyl groups 
had slightly elevated during the removal of T1, their mean 
values were not significantly (p>0.05) different to their 
respective baseline values. During the removal of T2, a further 
increase in F50 was evident, with the mean values in all 
treatment groups being significantly (p<0.01) higher than their 
respective baseline values. Additionally, the mean F50 at T2 in 
the butorphanol and fentanyl groups was significantly (p<0.05) 
higher than that at T1 and that of the morphine group at T2. 
Mean Ptot during the removal of T1 as well as T2 in all the 
four groups (excluding morphine after the removal of T2) was 
significantly (p<0.05) lower, compared with respective baseline 
values (Fig. 2). Also, cats in the buprenorphine and fentanyl 
groups had significantly (p<0.05) lower Ptot values during the 
removal of both testicles, compared to those in the morphine 
treated cats. However, there were no significant (p>0.05) 
differences in the Ptot means between the two surgical time-
points in all the four groups.  
 
There were no significant differences (p>0.05) in mean F95 
either between treatment groups or between time-points within 
groups (Fig. 3).  
 
No significant (p>0.05) differences between the treatment 
groups were observed with respect to the overall mean 
respiratory rate, heart rate, blood pressure,  ETCO2 and or ETHal 




The aim of this study was to investigate the effects of opioids 
on EEG indices of nociception in cats undergoing castration. 
The study further validates the use of EEG to assess the anti-
nociceptive efficacy of opioids in cats. Significant increases in 
F50, with concomitant decreases in Ptot of the EEG, were 
evident during the removal of testicles 1 and 2. During the 
removal of T1, cats treated with buprenorphine and butorphanol 
had a significantly higher F50, compared with that of the 
baseline period. A significant increase in F50 has previously 
been demonstrated to be associated with nociception in 
castrated dogs and ponies [7, 14]. During castration, tension on 
the spermatic cord and cremaster muscle might cause visceral 
nociception [11]. Buprenorphine is a partial agonist at µ-opioid 
receptors and considered to have a slow onset of action and a 
lesser degree of anti-nociception when administered 
subcutaneously [15, 16]. Buprenorphine administered by IV 
and intramuscular (IM) routes produced better and faster 
postoperative analgesia than by SC and oral trans-mucosal 
routes in cats undergoing ovariohysterectomy [17]. 
Pharmacokinetic-pharmacodynamic (PK-PD) studies in 
 
Figure 1. Least square mean (± standard error), in logarithmic scale, for F50 
EEG variable before and during removal of testicles 1 and 2 in cats 
administered four opioids.  
 
Figure 2. Least square mean (± standard error), in logarithmic scale, for Ptot 
EEG variable before and during removal of testicles 1 and 2 in cats 
administered four opioids. 
 
Figure 3. Least square mean (± standard error), in logarithmic scale, for F95 
EEG variable before and during removal of testicles 1 and 2 in cats 
administered four opioids.  
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conscious cats have demonstrated that SC buprenorphine 
results in an erratic absorption and disposition whereas its IV 
and IM administration follows a standard disposition, 
absorption and elimination pattern [18]. To date, there are no 
PK-PD data available for SC buprenorphine in cats under 
anesthesia. From the available studies it appears that the route 
of administration is important for buprenorphine to produce 
analgesia. In the current study, subcutaneously administered 
buprenorphine (0.01 mg/kg) would not have reached a plasma 
concentration (85-100 minutes after administration) high 
enough to prevent afferent noxious transmission during the 
removal of the testicles, as reflected by the observed increase in 
F50 of the EEG. The SC route is easier to administer drugs than 
IV injection and considered to be less painful than IM injection 
[19]. 
 
Butorphanol has been considered as a partial antagonist at µ-
opioid receptors, and produces analgesia through its k-agonist 
activity [20]. It has been demonstrated to produce better 
analgesia against acute visceral pain (e.g. interstitial cystitis) 
than somatic pain [21, 22], and is considered to be a poor 
analgesic for surgical pain management [23]. In the present 
study, cats administered 0.2 mg/kg of butorphanol SC showed 
no reduction in afferent transmission of noxious input during 
the removal of both testicles. Pure µ-opioid agonist agents can 
effectively reduce or prevent afferent noxious transmission 
when administered pre-emptively [24]. Because of its 
antagonistic action at µ-receptors, butorphanol was not 
expected to reduce the raise in F50 during castration, especially 
compared with morphine (which is a full agonist at µ-
receptors).  
 
Fentanyl is a short- acting µ-opioid agonist with a greater 
potency than morphine. It is commonly administered as a 
continuous rate infusion, transdermal patch or IV bolus in small 
animals. In the present study, mean F50 of the cats in the 
fentanyl group increased significantly (p<0.05) during removal 
of T2 compared to that of T1 and baseline time-periods. 
Following an IV administration (10 µg/kg), fentanyl was shown 
to reach a maximum plasma concentration by 2 minutes and the 
concentrations were undetectable after 95 min in conscious cats 
[15]. No reports are available for PK-PD data for SC fentanyl 
in cats. A study in greyhound dogs found that SC fentanyl was 
rapidly absorbed, reaching a peak plasma concentration in 0.24 
h (14.4 min), with a mean terminal elimination half-life of 2.97 
hours [25]. Plasma concentrations greater than 1 ng/mL were 
found to be effective in cats [15]. In the present study, fentanyl 
(5 µg/kg) administered SC 85-100 min prior to the incision 
reduced afferent noxious transmission during the removal of T1 
but not during T2 removal (seen as an increase in F50). This 
could likely be due to the result of rapidly declining levels of 
fentanyl, leading to ineffective reduction in the afferent 
transmission of the noxious stimuli, following the removal of 
T2, through the already sensitized neurons (due impulses from 
the removal of T1).  
 
Morphine is a full agonist at µ-opioid receptors and has been 
used extensively in cats at doses of 0.1 to 0.2 mg/kg that 
provided effective analgesia [26]. In the present study, there 
were no significant changes in F50 in morphine treated cats 
during the ligation of T1.  This is similar to the findings in dogs 
that demonstrated blunting of changes in F50 with SC morphine, 
following castration and electrical stimulation [14, 27]. During 
ligation of T2, a slight but significant increase in the mean F50 
(p=0.056) was found in morphine treated cats in this study. 
Limited metabolism and increased sensitivity of neurons 
following T1 removal could have caused a marginal increase in 
afferent transmission during removal of T2 in the morphine 
treated cats.  
 
The magnitude of increase in mean F50 during the removal of 
T1 and T2 in morphine treated cats was significantly lower than 
that of other treatment groups. Onset of analgesia occurs about 
45–60 minutes after its SC administration [26]. In the present 
study, morphine administered 85–100 minutes prior to the 
incision would have reached sufficient levels in the plasma to 
reduce the transmission of noxious input more effectively than 
other opioids. Total EEG power (Ptot) of cats (Fig. 2) treated 
with buprenorphine, butorphanol and fentanyl decreased 
significantly from baseline following the removal of both 
testicles. Also, and the mean Ptot in the morphine group was 
significantly higher than that of the buprenorphine and fentanyl 
groups. This finding is consistent with that of a study [14] in 
dogs administered morphine pre-operatively. A decrease in 
PTOT has been linked to nociception [7] and related to a decrease 
in depth of anesthesia during noxious stimulation. It is likely 
that Ptot represents a different aspect of nociception than F50 [7]. 
 
  There were no significant differences in the mean F95 
responses (Fig. 3) either between the treatment groups or 
between time-points, within groups. Changes in F95 might be 
more representative of the level of general central nervous 
system depression rather than nociception [27]. This finding is 
consistent with that of the findings in dogs administered 
analgesics preemptively [14, 27]. In the present study, dose 
rates of the opioids were chosen based on their experimental or 
clinical use in cats [26]. 
 
Significant increase in F50 and a concomitant decrease in Ptot 
were evident in cats administered buprenorphine, butorphanol 
and fentanyl, following noxious stimulation. These EEG 
changes, which are indicators of nociception across different 
species of animals [7, 14, 28-32] were significantly less in cats 
administered morphine. These results indicate that opioid 
analgesics, acting at different opioid receptors with variable 
affinity, produce changes in the EEG that reflect their analgesic 
efficacy. In addition, this study demonstrates the usefulness of 
the EEG as a valid tool for evaluating analgesic efficacy in cats, 
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